The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. (Q51839697)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2003

Language	Label	Description	Also known as
English	The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.	scientific article published in February 2003

Statements

scholarly article

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. (English)

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

object named as

Evelyn Ullrich

4

0 references

Othmar G Engelhardt

1

object named as

Othmar G Engelhardt

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

author name string

Chris Boutell

2

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Anne Orr

3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Otto Haller

5

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Roger D Everett

6

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Experimental Cell Research

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

283

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

1

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

36-50

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Identification of three major sentrinization sites in PML

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Activation of androgen receptor function by a novel nuclear protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

SUMO-1 modification activates the transcriptional response of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Characterization of a novel serine/threonine kinase associated with nuclear bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML)

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

RanBP2 associates with Ubc9p and a modified form of RanGAP1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Identifiers

10.1016/S0014-4827(02)00025-3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51839697&oldid=1373085154"